| 2025 | 2024 | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 279,5 k € | +7.7% | 259,6 k € | -16.4% | 310,4 k € | -18.0% | 378,7 k € | +5.7% | 358,3 k € | +24.5% | 287,7 k € | +21.6% | 236,7 k € | -8.9% | 259,8 k € | +117.4% | 119,5 k € | -57.7% | 282,4 k € | +22.1% | 231,2 k € | +24.8% | 185,2 k € | -15.8% | 220,0 k € | -0.7% | 221,5 k € | +3.5% | 214,1 k € | +16.1% | 184,4 k € | -14.1% | 214,6 k € | +22.6% | 175,0 k € | |
| EBITDA | 113,2 k € | +34.7% | 84,1 k € | +22.7% | 68,5 k € | -54.4% | 150,3 k € | +38.0% | 109,0 k € | +24.4% | 87,6 k € | -14.3% | 102,2 k € | -38.4% | 165,9 k € | +671.7% | 21,5 k € | -82.9% | 126,0 k € | +120.9% | 57,0 k € | -8.4% | 62,3 k € | -49.4% | 123,1 k € | -6.6% | 131,8 k € | +22.7% | 107,4 k € | +1.8% | 105,5 k € | -26.8% | 144,1 k € | +33.0% | 108,3 k € | |
| Operating profit | 64,1 k € | +29.8% | 49,4 k € | +17.0% | 42,2 k € | -66.1% | 124,7 k € | +53.6% | 81,2 k € | +32.8% | 61,1 k € | -13.7% | 70,8 k € | -46.2% | 131,5 k € | +1266.9% | -11,3 k € | -116.0% | 70,4 k € | +2540.9% | 2,7 k € | +121.1% | -12,7 k € | -119.2% | 65,8 k € | -16.7% | 79,0 k € | +0.6% | 78,5 k € | +2.9% | 76,3 k € | -33.5% | 114,8 k € | +48.9% | 77,1 k € | |
| Profit/loss | 91,5 k € | +53.5% | 59,6 k € | +32.0% | 45,2 k € | -65.1% | 129,5 k € | +64.5% | 78,8 k € | +52.3% | 51,7 k € | -18.3% | 63,3 k € | +11.8% | 56,6 k € | +71.4% | 33,0 k € | -27.3% | 45,5 k € | +207.1% | -42,5 k € | -16.0% | -36,6 k € | -192.9% | 39,4 k € | -45.0% | 71,6 k € | -17.9% | 87,2 k € | +6.1% | 82,2 k € | -30.0% | 117,4 k € | +50.6% | 78,0 k € | |
| Equity | 1,0 M € | +0.1% | 1,0 M € | +1.0% | 1,0 M € | +0.0% | 1,0 M € | +4.6% | 959,5 k € | +19.9% | 800,5 k € | +6.9% | 748,8 k € | +9.2% | 685,5 k € | +9.0% | 628,9 k € | +5.5% | 595,8 k € | +8.3% | 550,4 k € | -7.2% | 592,8 k € | -5.8% | 629,4 k € | +6.7% | 590,1 k € | -32.1% | 868,5 k € | +11.2% | 781,2 k € | +11.8% | 699,0 k € | +20.2% | 581,5 k € | |
| Total assets | 2,6 M € | +4.5% | 2,5 M € | +7.2% | 2,3 M € | +1.8% | 2,3 M € | +3.4% | 2,2 M € | +24.3% | 1,8 M € | +4.1% | 1,7 M € | +6.1% | 1,6 M € | +6.7% | 1,5 M € | +0.0% | 1,5 M € | +6.9% | 1,4 M € | -2.9% | 1,4 M € | -1.4% | 1,5 M € | -20.3% | 1,8 M € | +91.8% | 951,3 k € | +10.5% | 860,7 k € | +13.0% | 762,0 k € | +17.4% | 649,0 k € | |
| Cash | 207,9 k € | +0.6% | 206,6 k € | -18.6% | 253,7 k € | +30.6% | 194,2 k € | +10.7% | 175,5 k € | -9.4% | 193,6 k € | -13.3% | 223,2 k € | -3.4% | 231,1 k € | +88.1% | 122,9 k € | -17.5% | 148,9 k € | -2.3% | 152,3 k € | -12.7% | 174,5 k € | -4.8% | 183,3 k € | -70.6% | 624,2 k € | +21.2% | 515,2 k € | +222.3% | 159,9 k € | +6.2% | 150,5 k € | -6.0% | 160,2 k € | |
| Debts | 1,6 M € | +7.6% | 1,4 M € | +12.5% | 1,3 M € | +2.9% | 1,2 M € | +2.4% | 1,2 M € | +30.1% | 936,3 k € | +3.1% | 908,4 k € | +2.6% | 885,5 k € | +3.2% | 858,4 k € | -3.7% | 891,4 k € | +10.0% | 810,6 k € | -1.9% | 825,9 k € | +0.7% | 820,2 k € | -33.4% | 1,2 M € | +1394.2% | 82,5 k € | +4.0% | 79,3 k € | +25.8% | 63,0 k € | +4.5% | 60,3 k € | |
| Staff | 3,4 | 3 | 4,3 | 4,6 | 5,1 | 3,5 | 2,5 | — | 2,3 | 2,3 | 2,8 | 2,6 | 2,3 | 2,1 | 2,1 | 1,7 | 1,6 | 1,6 | ||||||||||||||||||
Private limited company · Maldegem · incorporated on 18/06/1982 · 3,4 ETP
Private limited company profitable and well capitalised.
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
APOTHEEK VAN CLEEMPUT is a Private limited company incorporated in 1982. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Maldegem. It employs on average 3,4 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette